Law360, New York (July 27, 2012, 7:42 PM ET) -- Matrixx Initiatives Inc., maker of the cold remedy Zicam, has agreed to pay $4.5 million to settle an eight-year-old class action alleging the company violated securities laws by concealing reports that the medication may cause a permanent loss of the sense of smell, according to documents filed in Arizona federal court Friday.
Matrixx and lead plaintiff NECA-IBEW Pension Fund have reached an accord that would bring an end to a long-running suit that traveled all the way up to the U.S. Supreme Court before being remanded...
Zicam Maker Coughs Up $4.5M to Settle Shareholder Action
To view the full article, take a free trial now.
